JPRN-UMIN000003807已完成未知
A study for comparison of triple combination therapy (bucillamine, salazosulphapiridine and methotrexate) with TNF-blocking biologics and methotrexate combination therapy concerning efficacy and tolerability for rheumatoid arthritis - JaSTAR Study
Japan Association of Rheumatologists in Private Practice0 个研究点目标入组 160 人开始时间: 2010年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(Complication) Patients who had any of the following diagnoses or medical history: 1) Autoimmune disease except for Sjogren syndorome, and malignancy 2) Drug allergy 3) Severe heart, lung, liver. kidney and hematolodical disorders (Treatment) 4)Patient who recived intramuscular, intoravenous or epidural injection of corticosteroids within 4 weeks prior to the entry or during study 5)Patient who recived intraarticular corticosteroid at dose of over 20mg/month of prednisolone, and patients who recieved intraarticular corticosteroid at any dose within 4weeks prior to study entry or the day for observation of first end point 6)Patient who recived systemic corticosteroid with a dose of >10mg of predonisolone within 4 weeks prior to the study or during the study and Patients whose corticosteroid dose were changed within 4 weeks prior to the day for observation of first end point 7)Patient who received NSAIDs with an overdosage within 4 weeks prior to the study entry or during the study (Surgery) 8)Patient who had surgery judged to have an influence on this study by doctor 9)Patient who had the following treatment or procedure: plasma exchange, leukocyte depleted therapy or arthrocentesis against affected joint. except for the arthrocenesis following intraarticular injection of corticosteroid, within 4 weeks prior to the study entry or during the study (Others) 10)Patient who is in pregnancy, lactating, or with a possibility of the pregnancy and woman who hopes for pregnancy during study or within 1 month after the end of this study, and man who wishes his partner be pregnant during the study or within 3 months after the end of this study 11)Patient who can not go to a hospital for check-up on an appointed day 12)Patient who participated other clinical trial program within 4 months prior to the study entry (including post-marketing clinical study) 13)When principal investigator or sub investigators of this study judge the patients disqualified as a subject of this study
研究者
相似试验
已完成
不适用
Treatment of Swallowing disorders in stroke patientsDysphagia.Difficulty in swallowingIRCT201202218629N1Tehran University of Medical Sciences15
招募中
3 期
Evaluation of the effect of interferon beta-1b in the treatment of COVID-19IRCT20200921048786N1Dezfoul University of Medical Sciences82
尚未招募
不适用
Comparison of three different combinations of ketofol for induction of general anaesthesiaCTRI/2021/07/034673Bijaya Chingtham
已完成
不适用
sefulness of visual analog scale for efficacy of medicines for asthma: Comparison between ICS/LABA/LAMA triple and ICS/LABA combination therapy - a retrospective cohort studyasthmaJPRN-UMIN000045636Kurume University School of Medicine308
尚未招募
3 期
Comparison of the effectiveness of topical minoxidl and cetirizine in androgenetic alopeciaIRCT20230308057655N1Esfahan University of Medical Sciences62